• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Obesity phenotypes in midlife linked to cognitive decline in old age

bys25qthea
October 3, 2012
in Chronic Disease, Neurology, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Image: CC/PLoS

Key study points:

1.     Obese-metabolically normal and obese-metabolically abnormal patients had similar cognitive levels during baseline and cognitive decline after 10 years

2.     In the metabolically abnormal group, the decline in global cognitive score (reasoning, memory and verbal fluency) was significantly greater in obese patients than in normal patients over the 10-year period (p = 0.03), even though there was no difference at baseline (p = 0.74).

Primer: Obesity is the number one growing health problem in the world. In 2008, the WHO estimated that over 500 million men and women were clinically defined as obese. Not only does it have implications on cardiovascular health, but obesity has also has been associated with many different diseases such as diabetes and increased risk of certain cancers. Recently, interest has turned to how obesity can affect cognitive function. Research has found that higher BMIs were associated with a poorer cognitive function and with a faster decline in cognitive performance in healthy men and women. Furthermore, it has been shown that obesity during middle-age is positively correlated with an increased risk of dementia. In this study, the authors wanted to distinguish whether an unfavorable metabolic profile regardless of BMI could be associated with decreases in cognitive capacity.

Background Reading:

RELATED REPORTS

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

1.     Cournot M, et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 2006;67:1208-1214.

This [prospective cohort] study: Data were collected from the Whitehall II cohort study, which included 10,308 British civil servants (67% men) in 1985. Only 6,401 individuals (71.2%) were included in this study. Individuals were stratified based upon their BMI (normal, overweight, obese) and metabolic profile (normal or abnormal). Individuals were defined as metabolically abnormal if they had 2 or more of hypertriglyceridemia, hypertension, diabetes or low HDL. The patients also underwent 3 series of cognitive testing between 1997-2009. These tests examined their memory, reasoning and verbal fluency and were aggregated to form a global score.

The study demonstrated that increased BMI was inversely correlated with cognitive functions in the metabolically normal group at baseline. However, there was no difference in cognitive capacity in the metabolically abnormal group. Over the 10-year period, the study revealed that a larger BMI was significantly associated with a decline in the global score only in individuals who were metabolically abnormal (p = 0.03).

In sum: The study was a large cohort study that examined the relationship between cognitive function, body mass index and metabolic profiles. The study concluded that BMI was positively correlated with a decline in cognitive function in patients with metabolic abnormalities, but obese patients had similar cognitive defects regardless of their metabolism. This study elucidates one of the many ongoing sequelae of obesity, metabolic disease and their interactions.  Plausible explanations for the associations seen include vascular disease as well as the accelerated aging seen in obese individuals.

There were several limitations to this study. As a cohort study, only associations, not causal relationships, could be inferred from the data. Furthermore, the data from this study is not representative of the British community since unemployed and blue-collar professionals were not included in the analysis. However, the strengths of study were its large sample size, and the comprehensive cognitive testing. Further research in this field should assess whether the duration of metabolic abnormalities affects the changes in cognitive function over time.

Click to read the study in Neurology

By JC and MP

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

HPV vaccine associated with minimal adverse effects

Next Post

High upstage rate among nonmalignant papillary breast lesions diagnosed by image-guided core needle biopsy

RelatedReports

Emergency

Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants

September 25, 2026
Artificial Intelligence

An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis

September 25, 2026
Chronic Disease

Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy

September 24, 2026
Artificial Intelligence

Large language models (LLMs) demonstrated the ability to generate accurate research manuscripts but required human oversight for more complex analyses

September 24, 2026
Next Post

High upstage rate among nonmalignant papillary breast lesions diagnosed by image-guided core needle biopsy

Vitamin D supplementation does not decrease incidence of viral upper respiratory tract infections

Right ventricular structure associated with an increased risk of heart failure and cardiovascular death; (MESA) Right ventricle study

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.